A5101983847- Palliative Care and End-of-Life Issues
- Cancer survivorship and care
- Lung Cancer Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Genetic factors in colorectal cancer
- Lung Cancer Research Studies
- Childhood Cancer Survivors' Quality of Life
- Patient Dignity and Privacy
- Ovarian cancer diagnosis and treatment
- Cytokine Signaling Pathways and Interactions
- Cardiac Imaging and Diagnostics
- Helicobacter pylori-related gastroenterology studies
- Cardiac, Anesthesia and Surgical Outcomes
- CAR-T cell therapy research
- Cancer therapeutics and mechanisms
- Wnt/β-catenin signaling in development and cancer
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Chronic Lymphocytic Leukemia Research
- Radiomics and Machine Learning in Medical Imaging
- Energy Harvesting in Wireless Networks
- Palliative and Oncologic Care
- Peptidase Inhibition and Analysis
- Brain Metastases and Treatment
Hospital Universitario Puerta de Hierro Majadahonda
2019-2025
Universidad Autónoma de Madrid
2023-2024
Abstract Introduction: Trophoblast cell-surface antigen 2 (Trop-2) has become an attractive antibody drug conjugate (ADC) target as it is expressed in multiple solid tumors. Sacituzumab govitecan (SG), ADC composed of a Trop-2 coupled to SN-38 by hydrolysable linker, demonstrated activity and approved metastatic triple-negative breast cancer hormone receptor-positive/human epidermal growth factor receptor 2-negative cancer. EVOKE-01 (NCT05089734) evaluated the efficacy safety SG vs docetaxel...
The complexity of cancer care requires planning and analysis to achieve the highest level quality. We aim measure quality provided patients with non-small cell lung (NSCLC) using data contained in hospital's information systems, order establish a system continuous improvement. Retrospective observational cohort study conducted university hospital Spain, consecutively including all NSCLC treated between 2016 2020. A total 34 indicators were selected based on literature review clinical...
Abstract Purpose The increase in the prevalence "long-term cancer survivor” (LCS) patients is expected to cost of LCS care. aim this study was obtain information that would allow optimise current model health management Spain adapt it one efficient patient Methods This qualitative carried out using Delphi methodology. An advisory committee defined criteria for participation, select panel experts, prepare questionnaire, interpret results and draft final report. Results 232 people took part...
Background: There is increasing interest in unplanned care utilization among lung cancer patients and its evaluation should allow the identification of areas for quality improvement. Being a major priority transformation oncology, we aim to measure risk burden medical oncology department identify factors that determine acute care. Methods: This was an observational retrospective cohort study included all treated at Puerta de Hierro-Majadahonda University Hospital between January 1st 2016...
Abstract Background Hereditary diffuse gastric cancer (HDGC) (OMIM# 137215) is an autosomal dominant syndrome associated with CDH1 192090) mutations. Prophylactic total gastrectomy (PTG) the most recommended preventive treatment when a pathogenic mutation found. However, increasing use of genetic testing has led to identification incidental mutations in individuals without family history cancer. It remains unclear whether these patients should undergo prophylactic gastrectomy. Methods...